- 全部删除
您的购物车当前为空
RMC-6291 是一种可口服且具有高效性的 KRASG12C(ON) 抑制剂,具有抗癌抗肿瘤活性,通过空间阻断 RAS 效应子结合来发挥作用。RMC-6291 阻断 ERK 信号传导,促使 KRASG12C 突变 H358 细胞凋亡。


为众多的药物研发团队赋能,
让新药发现更简单!
RMC-6291 是一种可口服且具有高效性的 KRASG12C(ON) 抑制剂,具有抗癌抗肿瘤活性,通过空间阻断 RAS 效应子结合来发挥作用。RMC-6291 阻断 ERK 信号传导,促使 KRASG12C 突变 H358 细胞凋亡。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,690 | In stock | |
| 2 mg | ¥ 4,480 | In stock | |
| 5 mg | ¥ 7,920 | In stock | |
| 10 mg | ¥ 10,900 | In stock | |
| 25 mg | ¥ 15,900 | In stock | |
| 50 mg | ¥ 21,800 | In stock | |
| 100 mg | ¥ 29,300 | In stock |
RMC-6291 相关产品
| 产品描述 | RMC-6291 is an orally available, highly potent KRASG12C(ON) inhibitor with anticancer and antitumor activity that acts through spatial blockade of RAS effector binding.RMC-6291 blocks ERK signaling and induces apoptosis in KRASG12C-mutant H358 cells. |
| 体内活性 | RMC-6291 (200mg/kg, 口服, 每日一次, 60天) 在小鼠肿瘤模型中显著抑制肿瘤生长并诱导免疫记忆。[1] |
| 别名 | RMC6291, RMC 6291, 2775304-30-6 |
| 分子量 | 1012.26 |
| 分子式 | C55H78FN9O8 |
| CAS No. | 2641998-63-0 |
| Smiles | O=C(C#CC(N(C)C)(C)C)N1CCC(F)(C(=O)N(C)C(C(=O)NC2C(=O)N3NC(C(=O)OCC(C)(C)CC=4C5=CC(=CC=C5N(C4C=6C=CC=NC6C(OC)C)CC)N7CCOC(C7)C2)CCC3)C(C)C)CC1 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (79.03 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容